TCL Archive DCPC Board Approves $40 Million In New Concepts, Including Three In Breast Cancer, One In Melanoma October 12, 1984
TCL Archive Recurrent Multiple Myeloma Responds To Revimid In Phase II, Side Effects Tolerable January 31, 2003
TCL Archive The NCI director and acting FDA commissioner called for faster approval of cancer drugs in speech to FDA staff. October 21, 2005
TCL Archive In Brief: Baker Leaves Wayne State To take Job as Deputy director, UM Cancer Center March 23, 1994
